Literature DB >> 15489631

Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis.

Luc Härter1, Ladislav Mica, Reto Stocker, Otmar Trentz, Marius Keel.   

Abstract

The reduced responsiveness of monocytes or granulocytes toward endotoxin (endotoxin tolerance) during sepsis may depend on Toll-like receptors (TLR). The expression of TLR-2 and TLR-4 was measured on neutrophils (PMN) and monocytes from patients with sepsis (n = 21) or healthy controls (n = 12). Leukocytes (1 x 10/mL) were incubated at 37 degrees C with or without a TLR-4 (LPS 1 microg/mL) or a TLR-2 ligand (MALP-2 2 nM). Surface expression of TLR-2 and TLR-4 at 0, 4, and 16 h was determined in FACS after staining with specific antibodies. The release of IL-8 and TNF-alpha was measured by ELISA. Freshly isolated PMN from patients with sepsis exhibited significantly (P < 0.05) higher mean fluorescence for TLR-2 (78.0 +/- 18.6) and TLR-4 (11.4 +/- 2.3) than controls (12.8 +/- 2.2 and 2.3 +/- 0.4). Similarly, monocytes from patients exhibited higher TLR-2 and TLR-4 expression (300.8 +/- 40.6 and 92.7 +/- 12.1) than cells from controls (149.5 +/- 27.1 and 52.2 +/- 7.6). In patients with sepsis, expression of TLR-2 and TLR-4 on PMN increased during 16 h of incubation (106.2 +/- 22.1 and 34.5 +/- 5.3), whereas it remained unchanged in controls (19.3 +/- 6.1 and 5.4 +/- 1.9). Incubation with LPS or MALP-2 had no effect on TLR-4 or TLR-2 expression in cells from either controls or patients. Despite increased TLR expression in cells from patients with sepsis, the endotoxin-induced release of TNF-alpha and IL-8 was indistinguishable from that in controls. Therefore, the endotoxin tolerance seen in patients with sepsis does not depend solely on TLR-2 or TLR-4 expression, and other mechanisms must be involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489631     DOI: 10.1097/01.shk.0000142256.23382.5d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  39 in total

1.  Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.

Authors:  Hong Yang; Shan Yu Fung; Aihua Bao; Qiang Li; Stuart E Turvey
Journal:  J Vis Exp       Date:  2017-07-26       Impact factor: 1.355

2.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

3.  Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.

Authors:  Patricia G Vallés; Silvia Melechuck; Adriana González; Walter Manucha; Victoria Bocanegra; Roberto Vallés
Journal:  Pediatr Nephrol       Date:  2011-10-05       Impact factor: 3.714

Review 4.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

5.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

6.  Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection.

Authors:  Angela Dolganiuc; Catherine Garcia; Karen Kodys; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 7.  Toll-like receptor 4 modulation as a strategy to treat sepsis.

Authors:  X Wittebole; D Castanares-Zapatero; P F Laterre
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711

8.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

Review 9.  Severe sepsis and Toll-like receptors.

Authors:  Hongmei Gao; Susannah K Leaver; Anne Burke-Gaffney; Simon J Finney
Journal:  Semin Immunopathol       Date:  2007-12-11       Impact factor: 9.623

10.  Effect of transforming growth factor-β1 on monocyte Toll-like receptor 4 expression in septic rats.

Authors:  Yu Zhang; Jing Xing
Journal:  World J Emerg Med       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.